As of March 2024 Novocure has a market cap of $1.56 Billion. This makes Novocure the world's 4519th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.56 B | -1.73% |
2023 | $1.59 B | -79.27% |
2022 | $7.69 B | -1.24% |
2021 | $7.79 B | -55.75% |
2020 | $17.61 B | 110.02% |
2019 | $8.38 B | 168.64% |
2018 | $3.12 B | 72.96% |
2017 | $1.80 B | 164.99% |
2016 | $0.68 B | -63.63% |
2015 | $1.87 B |
On Mar 27th, 2024 the market cap of Novocure was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $10.14 M | -99.35% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -75.76% | ๐ฌ๐ง UK |
Novavax NVAX | $0.67 B | -56.71% | ๐บ๐ธ USA |
Novocure
NVCR | $1.56 B | 0.00% | Jersey |